In contrast to the present clinical strategy, which focuses mostly on treating symptoms, regenerative medicine aims to restore tissue or organs that have been damaged by disease, trauma, or congenital abnormalities. Tissue engineering, cellular therapy, medicinal gadgets, and artificial organs are among the technologies employed to achieve these goals. Combinations of these treatments can speed up our natural healing process in areas where it's most required, or take over the function of an organ that's been irreversibly damaged. Regenerative medicine is a relatively young subject that brings together professionals from biology, chemistry, computer science, engineering, genetics, medicine, robotics, and other domains to solve some of humanity's most difficult medical challenges. The goal of regenerative medicine is to create and implement innovative treatments to mend tissues and organs and restore function that has been lost due to aging, disease, injury, or abnormalities. In many aspects, the human body has the natural ability to heal itself. Cell therapy and tissue engineering are two therapeutic methods used in regenerative medicine. Cell and tissue cultures are used in cell therapy approaches to replace morphological structures, tissues, and functions. Tissue engineering is a process that combines biological and technical techniques to construct structures and devices such as scaffolds, matrices, and 3D biocompatible materials to complement cell treatment.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States